Adipsic diabetes insipidus

Handb Clin Neurol. 2021:181:261-273. doi: 10.1016/B978-0-12-820683-6.00019-1.

Abstract

Adipsic diabetes insipidus (ADI) is a rare but devastating disorder of water balance with significant associated morbidity and mortality. Most patients develop the disease as a result of hypothalamic destruction from a variety of underlying etiologies. Damage to osmolar-responsive neuroreceptors, primarily within the supraoptic and paraventricular nuclei, results in impaired production and release of arginine vasopressin (AVP). Important regulating circuits of thirst sense and drive are regionally colocalized with AVP centers and therefore are also injured. Patients with central diabetes insipidus with impaired thirst response, defined as ADI, suffer from wide swings of plasma osmolality resulting in repeated hospitalization, numerous associated comorbidities, and significant mortality. Treatment recommendations are based largely on expert advice from case series owing to the rarity of disease prevalence. Acute disease management focuses on fixed dosing of antidiuretic hormone analogues and calculated prescriptions of obligate daily water intake. Long-term care requires patient/family education, frequent reassessment of clinical and biochemical parameters, as well as screening and treatment of comorbidities.

Keywords: Adipsia; Diabetes insipidus; Hypothalamus; Thirst; Water balance.

Publication types

  • Review

MeSH terms

  • Arginine Vasopressin
  • Diabetes Insipidus* / diagnosis
  • Diabetes Insipidus* / epidemiology
  • Diabetes Insipidus* / therapy
  • Diabetes Insipidus, Neurogenic*
  • Diabetes Mellitus*
  • Humans
  • Thirst
  • Water-Electrolyte Balance

Substances

  • Arginine Vasopressin